MedTrace Logo

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo

NCT00741182 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-03-18

No results posted yet for this study

Summary

The purpose of the study is to investigate, whether PTH(1-34) is able to promote fracture healing in postmenopausal women with fractures of the hip or shoulder.

Conditions

  • Shoulder Fractures
  • Trochanteric Fractures

Interventions

DRUG

rhPTH(1-34)

Injection of 20 micrograms per day in eight weeks

Sponsors & Collaborators

  • The Danish Medical Research Council

    collaborator OTHER

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Peter Schwarz, MD, DMSci · Glostrup University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00741182 on ClinicalTrials.gov